Iradimed Co Cash Flow Conversion Efficiency
Iradimed Co cash flow conversion efficiency. Based on the latest financial reports, Iradimed Co (IRMD) has a cash flow conversion efficiency ratio of 0.058x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($5.94 Million) by net assets ($101.75 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Iradimed Co (2012–2025)
Cash flow conversion efficiency of Iradimed Co from 2012 to 2025. This chart illustrates how Iradimed Co's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Iradimed Co stock quote for real-time trading data and today's change.
Iradimed Co Cash Flow Conversion Ratio Explained
Iradimed Co cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Iradimed Co Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Iradimed Co ranked by their cash flow conversion efficiency. Also see market cap of Iradimed Co for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Anhui Water Resources Development Co Ltd
SHG:600502
|
0.018x |
|
Drägerwerk AG & Co. KGaA (pref)
F:DRW3
|
0.037x |
|
MYT Netherlands Parent BV
NYSE:MYTE
|
0.045x |
|
Medartis Holding AG
SW:MED
|
0.019x |
|
Dongwon Ind
KO:006040
|
0.007x |
|
Suzhou Victory Precision Manufacture Co Ltd
SHE:002426
|
0.002x |
|
China Railway Tielong Container Logistics Co Ltd
SHG:600125
|
0.023x |
|
Paradise Co. Ltd
KQ:034230
|
0.028x |
Annual Cash Flow Conversion Efficiency for Iradimed Co (2012–2025)
The table below shows the annual cash flow conversion efficiency of Iradimed Co from 2012 to 2025. Review IRMD FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $94.62 Million | $24.95 Million | 0.264x | -10.67% |
| 2024-12-31 | $86.82 Million | $25.62 Million | 0.295x | +56.55% |
| 2023-12-31 | $71.42 Million | $13.47 Million | 0.189x | +38.31% |
| 2022-12-31 | $73.67 Million | $10.04 Million | 0.136x | -12.61% |
| 2021-12-31 | $72.17 Million | $11.26 Million | 0.156x | +64.59% |
| 2020-12-31 | $61.38 Million | $5.82 Million | 0.095x | -48.58% |
| 2019-12-31 | $55.52 Million | $10.23 Million | 0.184x | +4.80% |
| 2018-12-31 | $41.95 Million | $7.38 Million | 0.176x | +69.52% |
| 2017-12-31 | $32.93 Million | $3.42 Million | 0.104x | -64.83% |
| 2016-12-31 | $31.89 Million | $9.41 Million | 0.295x | +23.14% |
| 2015-12-31 | $31.93 Million | $7.65 Million | 0.240x | +93.53% |
| 2014-12-31 | $20.89 Million | $2.59 Million | 0.124x | -54.48% |
| 2013-12-31 | $5.42 Million | $1.47 Million | 0.272x | -41.98% |
| 2012-12-31 | $3.22 Million | $1.51 Million | 0.469x | -- |
About Iradimed Co
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible intravenous infusion pump systems and MRI compatible patient vital signs monitoring systems and related accessories. The company offers MRidium 3870 and 3860+ MRI Compatible IV Infusion Pump System with associated disposable IV tubing sets; 3880 MRI compatible patient vital signs moni… Read more